诺为泰发布全球疫苗临床试验概况综合报告

<!DOCTYPE html> <html lang="zh" xmlns:wb="//open.weibo.com/wb"> <head> <meta charset="utf-8"> <title>诺为泰发布全球疫苗临床试验概况综合报告 - 美国商业资讯</title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="description" content="悉尼--(美国商业资讯)-- Novotech（诺为泰）是一家专门与生物技术公司合作、加快各个阶段先进新型疗法的开发、可提供全方位服务的国际性临床合同研究组织 (CRO)。现在，诺为泰发布了《疫苗&mdash;&mdash;全球临床试验概况（2024年）》白皮书。报告深入剖析了疫苗开发领域的发"> <meta name="keywrods" content=""> <meta name="author" content="Business Wire China"> <link href="/css/bootstrap.css" rel="stylesheet"> <link href="/css/main.css?ver=20220804" rel="stylesheet"> <link href="/css/bootstrap-responsive.css" rel="stylesheet"> <script type="text/javascript" src="/js/jquery.min.js"></script> <script type="text/javascript" src="/js/bootstrap.js"></script> <script type="text/javascript" src="/js/main.js"></script>  <script src="//tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script> </head> <body>  <div class="header"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <div class="top_panel visible-desktop"> <a href="/zh">简体中文</a> | <a href="/hk">繁體中文</a> | <a href="/en">English</a> <div class="globalsite"><select id="globalsite" class="languages"><option value="0">美国商业资讯全球站点</option> <option value="1">Business Wire Global</option><option value="3">UK/Ireland</option><option value="4">Deutschland</option><option value="5">France</option><option value="6">Italy</option><option value="7">Japan</option> </select> </div> </div> <div class="logo"><a href="/zh"><img src="/images/bwlogo_webmain_china.png" alt="美国商业资讯" width="360" height="80"/></a></div> <div class="clear"></div> <div class="navigation"> <ul class="sf-menu"> <li class="current"><a href="/zh">首页</a> </li> <li><a href="/zh/news/index.html">新闻稿中心</a> </li> <li><a href="/zh/events/index.html">会展信息</a> </li> <li><a href="/zh/medias/index.html">媒体合作</a> </li> <li><a href="/zh/about/index.html">美国商业资讯</a> <ul> <li><a href="/zh/about/contact.html">联系我们</a></li> </ul> </li> </ul> <div class="clear"></div>  <div class="search_form visible-desktop"> <form action="/zh/news/search.html" method="get"> <input class="inp_search" name="s" type="text" value="搜索..." title="搜索..." /> <input type="submit" class="search_btn" value=" " /> </form> </div>  </div>  </div> </div> </div> </div>   <div class="page_wrapper"> <div class="wrap"> <div class="container"> <div id="content"> <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js?appkey=3616646312" type="text/javascript" charset="utf-8"></script> <script type="text/javascript" src="/js/swfobject.js"></script> <div class="full_980 main_wrap"> <div class="row"> <div class="span9 main_block story"> <p><img src="/files/logos/N/Novotech-TM-Verticle-logo-navy-new-tag.jpg" alt="Novotech"></p> <h2 class="storytitle">诺为泰发布全球疫苗临床试验概况综合报告</h2> <div class="storytimelang"> <span class="time">2024-11-25 11:00</span> <span class="lang"> <ul> <li><a href="/zh/news/58388.html"><img src="/images/zh_cn.png" alt="zh_cn"></a></li> <li><a href="/hk/news/58388.html"><img src="/images/zh_hant.png" alt="zh_hant"></a></li> <li><a href="/en/news/58388.html"><img src="/images/en.png" alt="en"></a></li> </ul> </span> <div class="clear"></div> </div> <ul class="industry-list"> <li><a href="/zh/industry/health-pharmaceutical.html" class="btn">医药和健康</a></li> </ul> <div class="storycontent"> <p> 悉尼--(美国商业资讯)-- Novotech（诺为泰）是一家专门与生物技术公司合作、加快各个阶段先进新型疗法的开发、可提供全方位服务的国际性临床合同研究组织 (CRO)。现在，诺为泰发布了<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Fwhitepapers%2Fvaccine-clinical-trials-global-landscape-whitepaper-2024%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Nov_Vaccines_WP_CHS%26utm_id%3D701Oc00000DZJJdIAP&esheet=54156608&newsitemid=20241122248653&lan=zh-CN&anchor=%26%2312298%3B%26%2330123%3B%26%2333495%3B%26%238212%3B%26%238212%3B%26%2320840%3B%26%2329699%3B%26%2320020%3B%26%2324202%3B%26%2335797%3B%26%2339564%3B%26%2327010%3B%26%2320917%3B%26%2365288%3B2024%26%2324180%3B%26%2365289%3B%26%2312299%3B%26%2330333%3B%26%2330382%3B%26%2320070%3B%26%2312290%3B&index=1&md5=da8212ff1902482c453c1e229e1495c9"><strong>《疫苗——</strong><strong>全球临床试验概况（2024</strong><strong>年）》白皮书。</strong></a>报告深入剖析了疫苗开发领域的发展态势，为生物技术与制药行业的利益相关者提供了宝贵的战略建议。</p> <p> 本新闻稿包含多媒体。此处查看新闻稿全文： <a href="https://www.businesswire.com/news/home/20241122248653/zh-CN/">https://www.businesswire.com/news/home/20241122248653/zh-CN/</a></p> <p> 白皮书探讨了预防性疫苗与治疗性疫苗试验的发展趋势，着重介绍了取得的进展以及各种新挑战。议题主要包括mRNA平台的发展、新型疫苗递送方式、以及世界卫生组织 (WHO) 和全球疫苗免疫联盟 (Gavi) 等组织为推动疫苗公平获取所做出的种种努力。</p> <p> <strong>主要亮点：</strong></p> <ul> <li> <strong>新趋势：</strong>当前，疫苗研发领域正在向适应性试验设计、个性化疫苗试验以及针对传染病和癌症治疗的新型递送方法转变。</li> <li> <strong>区域分析：</strong>分析了各区域临床试验的活跃程度，强调亚太地区在疫苗开发（尤其是治疗性疫苗）中日益增强的作用。</li> <li> <strong>投资概况：</strong>概述了传染病和肿瘤疫苗等风险投资和并购活动情况。</li> <li> <strong>监管动态：</strong>深入探讨了COVID-19大流行之后所建立的简化监管流程，从而加速疫苗的审批流程，并进一步提升全球对大流行病的防范与准备能力。</li> </ul> <p> <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Fwhitepapers%2Fvaccine-clinical-trials-global-landscape-whitepaper-2024%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Nov_Vaccines_WP_CHS%26utm_id%3D701Oc00000DZJJdIAP&esheet=54156608&newsitemid=20241122248653&lan=zh-CN&anchor=%26%2319979%3B%26%2336733%3B&index=2&md5=4c5749fe2ad4629f2b3111805230680f">下载</a>白皮书，了解应对监管复杂性、开展受试者招募以及利用新型疫苗技术的实用数据与战略指导。</p> <p> 点击<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Fwhitepapers%2Fvaccine-clinical-trials-global-landscape-whitepaper-2024%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Nov_Vaccines_WP_CHS%26utm_id%3D701Oc00000DZJJdIAP&esheet=54156608&newsitemid=20241122248653&lan=zh-CN&anchor=%26%2327492%3B%26%2322788%3B&index=3&md5=5aae82ffb2d39211233ecef889013f79">此处</a>，了解更多信息或获取《疫苗——全球临床试验概况（2024年）》报告。</p> <p> <strong>关于诺为泰</strong><a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Fabout%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Nov_Vaccines_WP_CHS%26utm_id%3D701Oc00000DZJJdIAP&esheet=54156608&newsitemid=20241122248653&lan=zh-CN&anchor=Novotech-CRO.com&index=4&md5=dde6ad4fb42e19ca1d90c709cfbf6931">Novotech-CRO.com</a></p> <p> <strong>Novotech（诺为泰）成立于1997年，是一家可提供全方位服务的专业生物技术合同研究组织 (CRO)，致力于加速临床各个阶段创新药物和先进疗法的开发。</strong></p> <p> 诺为泰因其在行业内的突出贡献而备受赞誉，曾荣获多项殊荣，其中包括弗若斯特沙利文2024年全球生物技术CRO奖 (Frost & Sullivan 2024 Global Biotech CRO Award)、2024年临床试验竞技场业务拓展、营销和创新卓越奖 (2024 Clinical Trials Arena Award for Excellence in Business Expansion, Marketing, and Innovation)、2024年优选雇主 (2024 Employer of Choice)、2024年美国Great Place to Work（卓越职场）认证 (2024 Great Place to Work in the US)、2024年布兰登·霍尔专业能力和技能发展金奖 (2024 Brandon Hall Gold Award)、2023年CRO领导力奖 (CRO Leadership Award 2023)、2023年亚太地区细胞与基因治疗临床试验卓越奖 (Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023) 和自2006年以来蝉联亚太地区合同研究组织年度公司奖 (Asia-Pacific Contract Research Organization Company of the Year Award)。</p> <p> 诺为泰是一家包含实验室、Ⅰ期临床中心、药物开发咨询和专业法规服务的临床CRO，拥有超5000项临床项目经验，包括Ⅰ期至Ⅳ期临床试验和生物等效性研究。诺为泰目前在全球34个办公地点共拥有3000多名员工，是值得信赖的战略合作伙伴。</p> <p> 要了解更多信息或与专家团队成员交谈，请访问<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Ftalk-to-an-expert%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Nov_Vaccines_WP_CHS%26utm_id%3D701Oc00000DZJJdIAP&esheet=54156608&newsitemid=20241122248653&lan=zh-CN&anchor=www.Novotech-CRO.com&index=5&md5=c0de943d2fe44f3ee686a86d34165fea">www.Novotech-CRO.com</a></p> <p> 在 businesswire.com 上查看源版本新闻稿: <a href="https://www.businesswire.com/news/home/20241122248653/zh-CN/">https://www.businesswire.com/news/home/20241122248653/zh-CN/</a></p> <p> <strong>CONTACT: </strong></p> <p> <strong>媒体联系信息 </strong><br /> <strong>Toyna Chin </strong><br /> <a href="mailto:mediacontact@novotech-cro.com">mediacontact@novotech-cro.com </a><br /> 美国：+1 415 364 8135</p> <div class="story-image"> <img src="/files/news/54156608-1732503880-1.jpg" alt="疫苗——全球临床试验概况（2024年）"/> <p class="caption">疫苗——全球临床试验概况（2024年）</p> </div> </div> <div class="subjects"> <ul class="subject-list"> <li><a href="/zh/subject/products-services.html">产品服务</a></li> </ul> </div>  <div id="ckepop"> <span class="jiathis_txt">分享到：    </span> <a class="jiathis_button_tsina"></a> <a class="jiathis_button_tqq"></a> <a class="jiathis_button_renren"></a> <a class="jiathis_button_kaixin001"></a> <a class="jiathis_button_tsohu"></a> <a class="jiathis_button_t163"></a> <a class="jiathis_button_fb"></a> <a class="jiathis_button_googleplus"></a> <a class="jiathis_button_tifeng"></a> <a class="jiathis_button_thexun"></a> <a class="jiathis_button_cnfol"></a> <a class="jiathis_button_txinhua"></a> <a class="jiathis_button_linkedin"></a> <a href="http://www.jiathis.com/share" class="jiathis jiathis_txt jtico jtico_jiathis" target="_blank"></a> </div> <script type="text/javascript" src="http://v3.jiathis.com/code/jia.js?uid=1344225902068353" charset="utf-8"></script> <div class="clear"></div> <div class="commentbox"> <wb:comments url="auto" border="y" width="auto" skin="blue" appkey="3616646312" ></wb:comments> </div> </div> <div class="span3 sidebar"> <div class="widget"> <h3>美国商业资讯微博</h3> <wb:follow-button uid="2676312451" type="red_2" width="136" height="24" ></wb:follow-button> </div> <div class="widget"> <h3>新闻稿中心</h3> <ul class="industry"> <li><a href="/zh/industry/corporate-social-responsibility">企业社会责任</a></li> <li><a href="/zh/industry/manufacturing">制造业</a></li> <li><a href="/zh/industry/chemical">化工</a></li> <li><a href="/zh/industry/health-pharmaceutical">医药和健康</a></li> <li><a href="/zh/industry/property">建筑和房地产</a></li> <li><a href="/zh/industry/travel">旅游</a></li> <li><a href="/zh/industry/automotive">汽车</a></li> <li><a href="/zh/industry/life-entertainment">生活和娱乐</a></li> <li><a href="/zh/industry/energy-environmental">能源和环境</a></li> <li><a href="/zh/industry/retail">零售</a></li> <li><a href="/zh/industry/transportation">运输和物流</a></li> <li><a href="/zh/industry/business-ecommerce">商务</a></li> <li><a href="/zh/industry/communications-media">通信和传媒</a></li> <li><a href="/zh/industry/metals-mining">金属和矿产</a></li> <li><a href="/zh/industry/finance">金融</a></li> <li><a href="/zh/industry/technology">高科技</a></li> <li><a href="/zh/industry/sports">体育</a></li> <li><a href="/zh/industry/education">教育</a></li> <li><a href="/zh/industry/art-culture">艺术文化</a></li> <li><a href="/zh/industry/legal">法律</a></li> </ul> </div> <div class="widget"> <h3>最新新闻稿</h3> <ul class="story"> <li><span class="time">2024-11-26 16:22</span><br/><a href="/zh/news/58402.html">Kolmar BNH凭借环保保健品HemoHIM彻底改变环境、社会和治理</a></li> <li><span class="time">2024-11-26 13:03</span><br/><a href="/zh/news/58400.html">LTIMindtree和Microsoft联手为全球企业加速AI创新和数字化转型</a></li> <li><span class="time">2024-11-26 12:58</span><br/><a href="/zh/news/58399.html">EH Group和NIM签署谅解备忘录，为海运业推进零排放氢燃料电池解决方案</a></li> <li><span class="time">2024-11-26 12:51</span><br/><a href="/zh/news/58398.html">FIFA宣布Rock-it Cargo成为FIFA World Cup 26™官方物流供应商并与其签订多年协议</a></li> <li><span class="time">2024-11-25 11:53</span><br/><a href="/zh/news/58393.html">泰雷兹拓展CipherTrust数据安全平台即服务产品系列</a></li> </ul> </div> </div> </div> </div> </div> </div> </div> </div>   <div id="footer" class="hidden-phone"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <a href="#" id="totop_btn" class="visible-desktop visible-tablet" title="回到顶端"></a>   <div class="footer_top"> <div class="col940"> <div class="row"> <div class="span4"> <h4>上海</h4> <p class="foot_home">上海市江宁路167号新城大厦1502室</p> <p class="foot_phone">+86 21 5239 8905</p> <p class="foot_email"><a href="mailto:sh@businesswirechina.com">sh@businesswirechina.com</a></p> </div> <div class="span4"> <h4>Business Wire Hong Kong</h4> <p class="foot_home">51/F Hopewell Centre, 183 Queen's Road East<br/>Wan Chai, Hong Kong</p> <p class="foot_phone">+852 3602 3091</p> <p class="foot_email"><a href="mailto:hk@businesswire.com">hk@businesswire.com</a></p> </div> <div class="span4"> <h4 style="text-align: center;text-transform:none;">官方微信：Interfax_China</h4> <p style="text-align: center;"><img src="/images/wechat-bwchina.jpg" style="width:160px" alt="官方微信：Interfax_China"/> </p> </div> </div> </div> </div> <div class="footer_bottom"> <div class="fleft"> <div class="copyright">© 2008-2018 Interfax Business Wire Services 版权所有，未经许可不得转载。</div> </div> <div class="clear"></div> </div>  </div> </div> </div> </div> <script type="text/javascript"> var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-669196-13']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); </script> <script language="javascript"> $(document).ready(function() { $("#globalsite").bind("change",function(){ var links = ['','http://www.businesswire.com','http://www.businesswire.ca/','http://www.businesswire.co.uk/','http://www.businesswire.de/','http://www.businesswire.fr/','http://www.businesswire.it/','http://www.businesswire.jp/']; var val = $(this).val(); var link = links[val]; if(link.length>0) { window.open(link); } }); }); </script> </body> </html>

CINXE.COM

诺为泰发布全球疫苗临床试验概况综合报告 - 美国商业资讯